Skip to content

Clinical study about the skin care of the skin disease patient

Clinical study about the skin care of the skin disease patient - Clinical study about the skin care of the skin disease patient

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010285
Enrollment
20
Registered
2013-04-01
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis, psoriasis, senile xerosis, contact dermatitis, etc.

Interventions

In addition to the usual treatment, test the products to use.

Sponsors

Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: In patients with symptoms of dry skin and pigmentation, target persons who meet the following criteria. In the people of the disease with the symptom of atopic dermatitis, psoriasis, senile xerosis, drying of the skin such as contact dermatitides and the pigmentation, the use of this study product is a use and a judged person in the treatment of the underlying disease The person that the symptom of the underlying disease is stable by treatment Age, the sex do not matter The person that a written agreement is provided from the person himself

Exclusion criteria

Exclusion criteria: Person with the experience that produced the skin symptoms such as contact dermatitides by this study product ingredient and similar ingredient Person with the exanthem that is unsuitable for the application of this study product in the application part The person that the symptom of the underlying disease is not stable The person whom (as a general rule) cannot examine 12 weeks later Person of pregnancy and nursing addition, the person that an examination responsibility (allotment) doctor judges the participation in this study to be inappropriate

Design outcomes

Primary

MeasureTime frame
At the start, 6 weeks later, at the end (12 weeks) to observe the changes in the skin symptoms.

Countries

Japan

Contacts

Public ContactKatsuko Kikuchi

Tohoku University Graduate School of Medicine Department of Dermatology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026